FRANKFURT – German pharmaceutical and agricultural company Bayer announced Tuesday that its first-quarter operating profits climbed 9%, significantly exceeding Wall Street forecasts thanks to strong performance from its soybean seed operations.
The company’s adjusted earnings before interest, taxes, depreciation and amortization reached 4.45 billion euros, equivalent to $5.23 billion. This figure substantially beat the average analyst projection of 3.93 billion euros that had been compiled on Bayer’s corporate website.
The agricultural division, known as Crop Science, saw particularly impressive growth with profits surging 17.9% to reach 3.0 billion euros. Much of this increase stemmed from settling a soybean licensing conflict with industry competitor Corteva earlier this year.
Additionally, Bayer reaffirmed its currency-adjusted financial projections for 2026 results, indicating confidence in continued growth.
